Joseph Richardson Larbi

Joseph Richardson Larbi

24 Jun, 2025

Joseph has 20 years experience in medical device life cycle management and quality management systems (certified to ISO 13485, ISO 9001 & ISO/IEC17025).

Key experience includes preparation and maintenance of technical files, product safety and vigilance reporting, clinical evaluations, risk assessment, regulatory audits, CE and notified body opinion submissions.

Joseph has worked on diabetes management devices, nicotine replacement therapy (NRT) devices and pressurised metered dose inhalers (pMDI); Joseph has worked for small, medium and large Biotech companies such as Roche, OBG Pharmaceuticals and Kind Consumer Ltd.

Other Related Articles

Beyond Document Delivery: How a Compliance-First CER Strategy Helped Achieve a Successful Notified Body Review

Blog Medical Devices

Beyond Document Delivery: How a Compliance-First CER Strategy Helped Achieve a Successful Notified Body Review

22 Jul, 2026

Responsible Integration of Artificial Intelligence in Clinical Evaluation Reports

Blog Medical Devices

Responsible Integration of Artificial Intelligence in Clinical Evaluation Reports

21 Jul, 2026

Navigating the Nagoya Protocol in Pharmaceutical Regulatory Affairs

Blog Pharmaceutical

Navigating the Nagoya Protocol in Pharmaceutical Regulatory Affairs

15 Jul, 2026

Companion Diagnostic Studies Under IVDR: Regulatory Requirements, Study Design, and Clinical Evidence Generation

Blog Medical Devices

Companion Diagnostic Studies Under IVDR: Regulatory Requirements, Study Design, and Clinical Evidence Generation

08 Jul, 2026

Beyond “Inactive”: Mastering Type IV DMFs for Excipients Using IPEC Guidance

Blog Pharmaceutical

Beyond “Inactive”: Mastering Type IV DMFs for Excipients Using IPEC Guidance

02 Jul, 2026

Ethylene Oxide in Pharmaceuticals and Consumer products – Essential Intermediate, High-Risk Exposure – A Regulatory Deep Dive

Blog Pharmaceutical

Ethylene Oxide in Pharmaceuticals and Consumer products – Essential Intermediate, High-Risk Exposure – A Regulatory Deep Dive

26 Jun, 2026

How to Address Data Consistency Challenges in EU MDR Submissions: A CAPTIS® Perspective

Blog Medical Devices

How to Address Data Consistency Challenges in EU MDR Submissions: A CAPTIS® Perspective

17 Jun, 2026

From Supplier to Label: Mastering Allergen Statements in Drugs and Cosmetics

Blog Pharmaceutical

From Supplier to Label: Mastering Allergen Statements in Drugs and Cosmetics

05 Jun, 2026

View All